We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bayer, Novartis Settle MS Drug Dispute For $200M

Law360 (March 26, 2007, 12:00 AM EDT) -- After years of negotiations, drug makers Bayer AG and Novartis AG finally settled their dispute over multiple sclerosis drug Betaseron on Monday, agreeing to give Bayer full control of the product...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.